Madrigal Pharmaceuticals, Inc. Share Price
Stocks
MDGL
US5588681057
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
01:30:00 03/09/2026 am IST
|
5-day change | 1st Jan Change | ||
| 546.93 USD | +1.53% |
|
+1.49% | -6.08% |
| Market Cap | 1.24TCr 1.07TCr 1.01TCr 921.6Cr 1.72TCr 1,17600Cr 1.74TCr 12TCr 4.65TCr 60TCr 4.67TCr 4.57TCr 1,97500Cr | P/E 2026 * |
-85.3x | P/E 2027 * | 85.6x |
|---|---|---|---|---|---|
| Enterprise Value | 1.19TCr 1.03TCr 968.87Cr 882.76Cr 1.65TCr 1,12600Cr 1.66TCr 11TCr 4.45TCr 58TCr 4.48TCr 4.38TCr 1,89100Cr | EV / Sales 2026 * |
7.81x | EV / Sales 2027 * | 5.36x |
| Free-Float |
94.12% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Madrigal Pharmaceuticals, Inc.
| 1 day | +1.53% | ||
| 1 week | +1.49% | ||
| Current month | +1.28% | ||
| 1 month | +13.47% | ||
| 3 months | +20.77% | ||
| 6 months | +25.55% | ||
| Current year | -6.08% |
| 1 week | 523.29 |  | 551.45 |
| 1 month | 461.25 | | 551.45 |
| Current year | 416.21 | | 598.79 |
| 1 year | 393.6 | | 615 |
| 3 years | 119.76 | | 615 |
| 5 years | 52.33 | | 615 |
| 10 years | 9.85 | | 615 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Sibold
CEO | Chief Executive Officer | 59 | 08/09/2023 |
Mardi Dier
DFI | Director of Finance/CFO | 62 | 11/03/2024 |
David Soergel
CTO | Chief Tech/Sci/R&D Officer | 58 | 21/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Rebecca Taub
BRD | Director/Board Member | 74 | 01/07/2016 |
Richard Levy
BRD | Director/Board Member | 68 | 11/08/2016 |
James Daly
BRD | Director/Board Member | 64 | 27/06/2019 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 17/08/26 | Sell | General Counsel | -664 | 0.0029% | ||
| 15/08/26 | Free | Director | 1,725 | 0.0075% | ||
| 20/07/26 | Sell | Chief Executive Officer | -2,500 | 0.0108% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.53% | +1.49% | +25.41% | +196.44% | 1.24TCr | |
| +1.03% | -3.11% | +39.80% | +94.60% | 6.82TCr | |
| +1.62% | +2.43% | +48.66% | +88.33% | 6.42TCr | |
| +4.21% | +1.80% | -12.85% | +380.20% | 2.65TCr | |
| +1.83% | -7.77% | +3.17% | -14.91% | 2.56TCr | |
| +1.30% | -0.96% | +32.58% | -17.99% | 1.99TCr | |
| -0.38% | -12.42% | +224.86% | +373.18% | 1.71TCr | |
| +0.65% | -5.83% | +1.44% | +544.44% | 1.49TCr | |
| +2.88% | +4.33% | +57.42% | +162.82% | 1.41TCr | |
| +3.18% | -4.21% | +232.44% | +204.57% | 1.17TCr | |
| Average | +1.78% | -4.07% | +65.29% | +201.17% | 2.75TCr | |
| Weighted average by Cap. | +1.67% | -3.17% | +50.75% | +156.96% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 152.63Cr 131.67Cr 124.04Cr 113.01Cr 211.24Cr 14TCr 212.83Cr 1.47TCr 569.92Cr 7.37TCr 573.14Cr 560.61Cr 24TCr | 214.49Cr 185.04Cr 174.31Cr 158.82Cr 296.86Cr 20TCr 299.08Cr 2.06TCr 800.9Cr 10TCr 805.43Cr 787.82Cr 34TCr |
| Net income | -18Cr -16Cr -15Cr -14Cr -25Cr -1.74TCr -26Cr -176.91Cr -69Cr -888.02Cr -69Cr -68Cr -2.92TCr | 20Cr 17Cr 16Cr 15Cr 28Cr 1.89TCr 28Cr 192.42Cr 75Cr 965.92Cr 75Cr 73Cr 3.17TCr |
| Net Debt | -52Cr -45Cr -43Cr -39Cr -73Cr -4.95TCr -73Cr -504.66Cr -195.86Cr -2.53TCr -196.96Cr -192.66Cr -8.32TCr | -94Cr -81Cr -77Cr -70Cr -130.54Cr -8.91TCr -131.52Cr -907.51Cr -352.2Cr -4.56TCr -354.19Cr -346.44Cr -15TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | $546.93 | +1.53% | 2,02,800 |
| 01/26/01 | $538.71 | -0.24% | 1,65,754 |
| 31/26/31 | $540.03 | +1.17% | 1,34,578 |
| 28/26/28 | $533.76 | -1.83% | 2,68,664 |
| 27/26/27 | $543.69 | +0.89% | 2,21,853 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- MDGL Stock
Select your edition
All financial news and data tailored to specific country editions
